Spotlight Presentation: Engineered Enzymes to Overcome Scalability and Sustainability Challenges of Nucleic Acid Therapeutics Manufacturing
When: Sunday, May 7, Luncheon session
Speakers: Stephanie Forget Ph.D., Scientist II, Codexis & Matt Miller, Principal Scientist, Codexis
Ribonucleic acid as a therapeutic modality has gained tremendous traction in recent years; however, large-scale production faces complex challenges in nucleic acids quality and quantity, as well as overall economics. Targeting the growing number of mRNA vaccines in the marketplace and siRNA/ASO candidates advancing in clinical studies, we will share how engineered enzymes can overcome these difficulties to achieve scalable and sustainable manufacturing.
Visit us in Booth# 807